Study examines association between small-vessel disease, Alzheimer pathologyMay 12, 2014
Bottom Line: Cerebral small-vessel disease (SVD) and Alzheimer disease (AD) pathology appear to be associated.
Author: Maartje I. Kester, M.D., Ph.D., of the VU University Medical Center, Amsterdam, the Netherlands, and colleagues.
Background: AD is believed to be caused by the buildup of amyloid protein in the brain and tau tangles. Previous studies have suggested that SVD and vascular risk factors increase the risk of developing AD. In both SVD and vascular dementia (VaD), signs of AD pathology have been seen. But it remains unclear how the interaction between SVD and AD pathology leads to dementia.
How the Study Was Conducted: Authors examined the association between SVD and AD pathology by looking at magnetic resonance imaging (MRI)-based microbleeds (MB), white matter hyperintensities (WMH) and lacunes (which are measures for SVD) along with certain protein levels in cerebrospinal fluid (CSF) which reflect AD pathophysiology in patients with AD, VaD and healthy control patients. The authors also examined the relationship of apolipoprotein E (APOE) Ɛ4 genotype, a well-known risk factor for AD.
Results: The presence of both MBs and WMH was associated with lower CSF levels of Aβ42, suggesting a direct relationship between SVD and AD. Amyloid deposits also appear to be abnormal in patients with SVD, especially in (APOE) Ɛ4 carriers.
Discussion: "Our study supports the hypothesis that the pathways of SVD and AD pathology are interconnected. Small-vessel disease could provoke amyloid pathology while AD-associated cerebral amyloid pathology may lead to auxiliary vascular damage."
Editor's Note: The authors made conflict of interest and funding disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Media Advisory: To contact author Maartje I. Kester, M.D., Ph.D., email email@example.com
The JAMA Network Journals
Related Alzheimer Disease Articles:
In this paper, the researchers report on a straightforward expression and purification protocol to obtain [U-15N] and [U-2H,13C,15N] Aβ42.
Among adults who entered a study more than 25 years ago, an increasing number of midlife vascular risk factors, such as obesity, high blood pressure, diabetes, high cholesterol and smoking, were associated with elevated levels of brain amyloid (protein fragments linked to Alzheimer's disease) later in life, according to a study published by JAMA.
Researchers have uncovered a mechanism that helps block the accumulation of proteins involved in Alzheimer's disease.
Researchers at Ulsan National Institute of Science and Technology (UNIST) in South Korea have introduced a new approach to treat Alzheimer's disease.
A new study published by UAlberta researchers in the journal Alzheimer's and Dementia: Translational Research and Clinical Intervention examines if a compound called AC253 can inhibit a 'rogue' protein called amyloid.
Alzheimer's disease affects more than 35 million people, a number that is expected to increase in the coming years.
A study published today by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine describes that certain proteins playing a role in cancer progression and metastasis are stored as amyloid bodies in dormant cancer cells.
A research project has shown that an experimental model of Alzheimer's disease can be successfully treated with a commonly used anti-inflammatory drug.
While strokes are known to increase risk for dementia, much less is known about diseases of large and small blood vessels in the brain, separate from stroke, and how they relate to dementia.
Drugs used to treat diabetes could also be used to treat Alzheimer's disease, and vice versa, according to new research from the University of Aberdeen, published in Diabetologia (the journal of the European Association for the Study of Diabetes).
Related Alzheimer Disease Reading:
Alzheimer's Disease: What If There Was a Cure?: The Story of Ketones
by Mary T. Newport (Author)
In this second edition Dr. Newport, a neonatal practitioner, continues the story of Steve's progress and provides the most recent research on such topics as possible causes of Alzheimer's due to the herpes simplex virus and nitrosamine substances and how infection, inflammation and genetic makeup may affect an individual's response to fatty acid therapy. View Details
Alzheimer's Disease: What If There Was a Cure?: The Story of Ketones
by Mary T. Newport (Author)
Acting on new research showing that medium-chain fatty acids, which act like an alternative fuel in the insulin-deficient Alzheimer's brain, can sometimes reverse or at least stabilize the disease, author Dr. Mary T. Newport has demonstrated through her care for her husband that there is hope, relief, and perhaps a cure. View Details
by Dr. Paul Dash (Author), Dr. Nicole Villemarette-Pitman PhD (Author), Nicole Villemarette-Pittman (Author)
Alzheimer's Disease was a finalist for a 2005 ForeWord Book of the Year Award!
An estimated 5 million Americans suffer from Alzheimer's disease, only half of whom have been diagnosed. An uncertain but even larger number have mild cognitive impairment, often a precursor to Alzheimer's. By 2030, barring a cure for this illness, the number of individuals diagnosed with Alzheimer's disease is estimated to be 8 million, and by 2050, 14 million. The cost in both suffering and dollars on the part of patients and families is enormous and continues to grow worldwide.... View Details
Alzheimer's Disease: What If There Was a Cure? by Mary T. Newport 1st (first) Edition (10/7/2011)
by aa (Author)
Alzheimer's Disease: Prevention Strategies & Ways to Slow Progression
by Lisa Byrd (Author)
Nationally respected Gerontologist Lisa Bryd has brought together the latest preventative research, along with the newest techniques to slow age-related cognitive decline in a breakthrough book on the management of Alzheimer's. Filled with strategies, activities and approaches - cognitive interventions, exercise plans, diet solutions, ways to promote social engagement and medication treatments. Case studies and personal experiences highlight this must-have resource for anyone working with Alzheimer's, dementia and delirium patients. View Details
Alzheimer's Disease and Dementia: What Everyone Needs to Know®
by Steven R. Sabat (Author)
Alzheimer's is swiftly on the rise: it is estimated that every 67 seconds, someone develops the disease. For many, the words "Alzheimer's disease" or "dementia" immediately denote severe mental loss and, perhaps, madness. Indeed, the vast majority of media coverage of Alzheimer's disease (AD) and other types of dementia focuses primarily on the losses experienced by people diagnosed and the terrible burden felt by care partners yearning for a "magic bullet" drug cure.
Providing an accessible, question-and-answer-format primer on what touches so many lives, and yet so few of us... View Details
The Spectrum of Hope: An Optimistic and New Approach to Alzheimer's Disease and Other Dementias
by Gayatri Devi MD (Author)
Imagine finding a glimmer of good news in a diagnosis of Alzheimer’s. And imagine how that would change the outlook of the 5 million Americans who suffer from Alzheimer’s disease and other dementias, not to mention their families, loved ones, and caretakers. A neurologist who’s been specializing in dementia and memory loss for more than 20 years, Dr. Gayatri Devi rewrites the story of Alzheimer’s by defining it as a spectrum disorder—like autism, Alzheimer’s is a disease that affects different people differently. She encourages people who are worried about memory impairment to... View Details
Alzheimer's Disease Decoded: The History, Present, and Future of Alzheimer's Disease and Dementia
by Ronald Sahyouni (Author), Aradhana Verma (Contributor), Jefferson William Chen (Contributor)
The book aims to present, educate and inform individuals about Alzheimer's disease in a comprehensive manner. Its scope ranges from the discovery of the disease, epidemiology and basic biological principles underlying it, to advanced stem cell therapies used in the treatment of Alzheimer's. It adopts a "global" perspective on Alzheimer's disease, and include epidemiological data and science from countries around the world. Alzheimer's disease is a rapidly growing problem seen in every country around the world. This is the first and only comprehensive book to cover Alzheimer's disease, and... View Details
My Journey into Alzheimer's Disease
by Robert Davis (Author), Betty Davis (Author)
A book of encouragement of how one man of faith faced the oncoming darkness of Alzheimer's disease. In a powerful story of courage and faith, Davis shows how God gives strength and grace. View Details
A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier
by Patricia R. Callone (Author), Connie Kudlacek (Author), Barabara C. Vasiloff (Author), Janaan Manternach (Author), Roger A. Brumback (Author)
"An estimated 5 million Americans have Alzheimer's disease. That number continues to grow - by 2050 the number of individuals with Alzheimer's could range from 11.3 million to 16 million. Alzheimer's disease is not a normal part of aging. It is a devastating disorder of the brain's nerve cells that impairs memory, thinking, and behavior. Written for patients, their families, and caregivers, A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier will help readers understand what is physically happening to the brain so they can empower their own special skills and... View Details